“…NICE in January 2018 has updated Medical Technology Guidance 8 (MTG8) with the new Medistim devices, the MiraQ systems (MiraQ Cardiac, MiraQ Vascular, MiraQ Ultimate, Medistim, Oslo, Norway) by reviewing four recent studies . Capital and operating costs of the MiraQ systems, labor, and operative time for use of the MiraQ were plotted against the cost of patient complications that may be reduced with use of the MiraQ (MI, rehabilitation for MI, deep sternal wound infection, and use of the intra‐aortic balloon pump).…”